Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2019-05-09 Purchase | 2019-05-13 5:00 pm | Trevi Therapeutics Inc. | TRVI | VANLENT ANNE Director | 5,000 | $10 | $50,000 | 25,983 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-06-28 Option Award | 2023-06-30 4:00 pm | N/A 2033-06-27 | Trevi Therapeutics Inc. | TRVI | VANLENT ANNE Director | 30,000 | $0 | 30,000 (Direct) | View |
Ownership | 2023-01-03 4:27 pm | N/A 2031-05-27 | ObsEva SA | OBSV | VANLENT ANNE Director | 0 | $0 | 81,140 (Direct) | View |
| 2022-11-30 Disposition | 2022-12-01 09:23 am | N/A 2026-08-17 | APPLIED GENETIC TECHNOLOGIES CORP | AGTC | VANLENT ANNE Director | 80,000 | $0 | 0 (Direct) | View |
| 2022-06-23 Option Award(A) | 2022-07-01 4:59 pm | N/A 2032-06-22 | Trevi Therapeutics Inc. | TRVI | VANLENT ANNE Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2022-06-23 Option Award | 2022-06-23 5:01 pm | N/A 2032-06-22 | Trevi Therapeutics Inc. | TRVI | VANLENT ANNE Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2021-11-30 Option Award | 2021-12-02 7:00 pm | N/A 2031-11-30 | APPLIED GENETIC TECHNOLOGIES CORP | AGTC | VANLENT ANNE Director | 14,000 | $0 | 14,000 (Direct) | View |
| 2021-06-16 Option Award | 2021-06-17 4:01 pm | N/A 2031-06-15 | Trevi Therapeutics Inc. | TRVI | VANLENT ANNE Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2020-12-16 Option Award | 2020-12-18 5:50 pm | N/A 2030-12-16 | APPLIED GENETIC TECHNOLOGIES CORP | AGTC | VANLENT ANNE Director | 12,000 | $0 | 12,000 (Direct) | View |
| 2020-06-11 Option Award | 2020-06-15 5:03 pm | N/A 2030-06-10 | Trevi Therapeutics Inc. | TRVI | VANLENT ANNE Director | 14,210 | $0 | 14,210 (Direct) | View |
| 2019-12-04 Option Award | 2019-12-06 6:14 pm | N/A 2029-12-04 | APPLIED GENETIC TECHNOLOGIES CORP | AGTC | VANLENT ANNE Director | 10,000 | $0 | 10,000 (Direct) | View |
| 2019-06-12 Option Award | 2019-06-14 5:01 pm | N/A 2029-06-11 | Vaxart Inc. | VXRT | VANLENT ANNE Director | 21,700 | $0 | 21,700 (Direct) | View |
| 2019-05-09 Conversion | 2019-05-13 5:00 pm | N/A N/A | Trevi Therapeutics Inc. | TRVI | VANLENT ANNE Director | 176,767 | $0 | 25,983 (Direct) | View |
| 2019-05-07 Option Award | 2019-05-08 5:00 pm | N/A 2029-05-06 | Trevi Therapeutics Inc. | TRVI | VANLENT ANNE Director | 23,684 | $0 | 23,684 (Direct) | View |
Ownership | 2019-05-07 7:01 pm | N/A N/A | Trevi Therapeutics Inc. | TRVI | VANLENT ANNE Director | 0 | $0 | 39,398 (Direct) | View |